Article
Therapeutic role of interleukin-1 receptor antagonist in pancreatic diseases: mendelian randomization study
14 Sept 2023
Abstract excerpt
Background The interleukin-1 pathway has been linked to pancreatic diseases. We applied the Mendelian randomization approach to explore whether higher interleukin-1 receptor antagonist (IL-1RA) levels reduce the risk of acute and chronic pancreatitis and pancreatic cancer. Methods Genetic variants associated with blood IL-1RA levels at the genome-wide significance level and located 5MB downstream or upstream of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
